Evidence map›Paper›PMID 26931319›Full record

GuidelineStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2016

DEGRO practical guidelines for radiotherapy of breast cancer VI: therapy of locoregional breast cancer recurrences.

Wolfgang Harms, W Budach, J Dunst, P Feyer, R Fietkau, W Haase, D Krug, M D Piroth, M-L Sautter-Bihl, F Sedlmayer and 4 more

Abstract readPractice Guideline
In one paragraph

Guideline in Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 8 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 8 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Prospective randomized clinical studies involving reirradiation: update of a systematic review.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2023
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Shared decision making in breast cancer treatment guidelines: Development of a quality assessment tool and a systematic review.Health expectations : an international journal of public participation in health care and health policy · 2020
    Pooled it
  7. Pooled it
  8. Prospective randomized clinical studies involving reirradiation : Lessons learned.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2016
    Pooled it
  9. Review
  10. Article
  11. Article
  12. Moderately hypofractionated partial breast reirradiation: early clinical results and dosimetric considerations in the context of 2Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2025
    Review
  13. Criteria for Re-Irradiation.Deutsches Arzteblatt international · 2024
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Wolfgang HarmsAbteilung für Radioonkologie, St. Claraspital, Kleinriehenstrasse 30, 4016, Basel, Switzerland. wolfgang.harms@claraspital.ch.
W BudachHeinrich-Heine-University, Duesseldorf, Germany.
J DunstUniversity Hospital Schleswig-Holstein, Kiel, Germany.
P FeyerVivantes Hospital Neukoelln, Berlin, Germany.
R FietkauUniversity Hospital Erlangen, Erlangen, Germany.
W HaaseFormerly St.-Vincentius-Hospital, Karlsruhe, Germany.
D KrugUniversity Hospital Heidelberg, Heidelberg, Germany.
M D PirothHELIOS-Hospital Wuppertal, Witten/Herdecke University, Wuppertal, Germany.
M-L Sautter-BihlMunicipal Hospital, Karlsruhe, Germany.
F SedlmayerParacelsus Medical University Hospital, Salzburg, Austria.
R SouchonFormerly University Hospital Tuebingen, Tuebingen, Germany.
F WenzUniversity Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
R SauerUniversity Hospital Erlangen, Erlangen, Germany.
Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo update the practical guidelines for radiotherapy of patients with locoregional breast cancer recurrences based on the current German interdisciplinary S3 guidelines 2012.

methodsA comprehensive survey of the literature using the search phrases "locoregional breast cancer recurrence", "chest wall recurrence", "local recurrence", "regional recurrence", and "breast cancer" was performed, using the limits "clinical trials", "randomized trials", "meta-analysis", "systematic review", and "guidelines".

conclusionsPatients with isolated in-breast or regional breast cancer recurrences should be treated with curative intent. Mastectomy is the standard of care for patients with ipsilateral breast tumor recurrence. In a subset of patients, a second breast conservation followed by partial breast irradiation (PBI) is an appropriate alternative to mastectomy. If a second breast conservation is performed, additional irradiation should be mandatory. The largest reirradiation experience base exists for multicatheter brachytherapy; however, prospective clinical trials are needed to clearly define selection criteria, long-term local control, and toxicity. Following primary mastectomy, patients with resectable locoregional breast cancer recurrences should receive multimodality therapy including systemic therapy, surgery, and radiation +/- hyperthermia. This approach results in high local control rates and long-term survival is achieved in a subset of patients. In radiation-naive patients with unresectable locoregional recurrences, radiation therapy is mandatory. In previously irradiated patients with a high risk of a second local recurrence after surgical resection or in patients with unresectable recurrences, reirradiation should be strongly considered. Indication and dose concepts depend on the time interval to first radiotherapy, presence of late radiation effects, and concurrent or sequential systemic treatment. Combination with hyperthermia can further improve tumor control. In patients with isolated axillary or supraclavicular recurrence, durable disease control is best achieved with multimodality therapy including surgery and radiotherapy. Radiation therapy significantly improves local control and should be applied whenever feasible.

Indexed as

Breast NeoplasmsCarcinoma, DuctalCarcinoma, Intraductal, NoninfiltratingCombined Modality TherapyCooperative BehaviorFemaleGermanyHumansInterdisciplinary CommunicationMastectomyNeoplasm Recurrence, LocalRadiotherapy, AdjuvantReoperationRetreatmentAxillary recurrence breast cancerChest wall recurrence breast cancerMastectomyReirradiationSupraclavicular recurrence breast cancer

Identifiers

PMID26931319
PMCPMC4833793

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.